DrugPatentWatch Database Preview
Aaa Usa Inc Company Profile
» See Plans and Pricing
What is the competitive landscape for AAA USA INC, and what generic alternatives to AAA USA INC drugs are available?
AAA USA INC has two approved drugs.
There are three US patents protecting AAA USA INC drugs.
There are thirty-one patent family members on AAA USA INC drugs in twenty countries.
Drugs and US Patents for Aaa Usa Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aaa Usa Inc | NETSPOT | gallium dotatate ga-68 | POWDER;INTRAVENOUS | 208547-001 | Jun 1, 2016 | RX | Yes | Yes | Start Trial | Start Trial | |||||
Aaa Usa Inc | NETSPOT | gallium dotatate ga-68 | POWDER;INTRAVENOUS | 208547-001 | Jun 1, 2016 | RX | Yes | Yes | 9,375,498 | Start Trial | Y | Start Trial | |||
Aaa Usa Inc | LUTATHERA | lutetium dotatate lu-177 | SOLUTION;INTRAVENOUS | 208700-001 | Jan 26, 2018 | RX | Yes | Yes | 10,596,278 | Start Trial | Y | Start Trial | |||
Aaa Usa Inc | LUTATHERA | lutetium dotatate lu-177 | SOLUTION;INTRAVENOUS | 208700-001 | Jan 26, 2018 | RX | Yes | Yes | Start Trial | Start Trial | |||||
Aaa Usa Inc | LUTATHERA | lutetium dotatate lu-177 | SOLUTION;INTRAVENOUS | 208700-001 | Jan 26, 2018 | RX | Yes | Yes | Start Trial | Start Trial | |||||
Aaa Usa Inc | NETSPOT | gallium dotatate ga-68 | POWDER;INTRAVENOUS | 208547-001 | Jun 1, 2016 | RX | Yes | Yes | Start Trial | Start Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Aaa Usa Inc Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
European Patent Office | 2955168 | Start Trial |
Poland | 2742017 | Start Trial |
South Africa | 201401789 | Start Trial |
Israel | 230904 | Start Trial |
Canada | 2844145 | Start Trial |
New Zealand | 622071 | Start Trial |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.